Le Lézard
Classified in: Transportation, Health, Science and technology
Subject: IMA

Nippon Express (Belgium) Acquires GDP Certification for Facility in Brussels Airport's Cargo Area


TOKYO, Jan. 20, 2022 /PRNewswire/ -- Nippon Express (Belgium) N.V./S.A. (hereinafter "NX Belgium"), a company of the Nippon Express Holdings, Inc. Group, has obtained Good Distribution Practice (GDP) certification, effective December 21, 2021, for air and ground forwarding operations, inclusive of inventory control, at a facility in the cargo area of Brussels Airport, evidencing its compliance with GDP standards for the proper distribution of pharmaceuticals.

Logo: https://kyodonewsprwire.jp/img/202201176158-O3-bvsjuUa0

Photo1: Warehouse interior
https://kyodonewsprwire.jp/prwfile/release/M103866/202201176158/_prw_PI2fl_P21bPD7U.jpg

Belgium has become a hub for pharmaceutical manufacturing and development, hosting numerous global pharmaceutical companies as well as contract manufacturing organizations, vaccine manufacturers and biotechnology research laboratories.

NX Belgium has signed a business partnership agreement with Medexi, which specializes in pharmaceutical transport, and obtained GDP certification for operations at a Medexi-owned temperature-controlled 2,000 m2 facility dedicated to pharmaceutical products and capable of both refrigerated (2C - 8C) and constant-temperature (15C - 25C) storage. Medexi's pharmaceutical knowledge and advanced operational quality will be combined with the NX Group's international temperature-controlled transport services and warehouse storage functions to provide customers with a pharmaceutical logistics platform.

The NX Group will continue stepping up its initiatives in the pharmaceutical industry, identified as a priority industry in the Group's Business Plan, and globally enhancing and expanding its services to meet the increasingly sophisticated and diversified pharmaceutical transport needs of its customers.

Name and address of company
Name: Nippon Express (Belgium) N.V./S.A.
Address: Bedrijvenzone Machelen Cargo 738/1, Machelen Belgium

Nippon Express website: https://www.nipponexpress.com/

Official LinkedIn account: NX GROUP
https://www.linkedin.com/company/nippon-express-group/

SOURCE Nippon Express Holdings, Inc.


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: